The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
Human cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV gen...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2025-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/96414 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839640410892271616 |
---|---|
author | Fabienne Maassen Vu Thuy Khanh Le-Trilling Luisa Betke Thilo Bracht Corinna Siegmund Malte Bayer Benjamin Katschinski Antonia Belter Tanja Becker Denise Mennerich Sebastian Voigt Lori Frappier Barbara Sitek Katharina Fleischhauer Mirko Trilling |
author_facet | Fabienne Maassen Vu Thuy Khanh Le-Trilling Luisa Betke Thilo Bracht Corinna Siegmund Malte Bayer Benjamin Katschinski Antonia Belter Tanja Becker Denise Mennerich Sebastian Voigt Lori Frappier Barbara Sitek Katharina Fleischhauer Mirko Trilling |
author_sort | Fabienne Maassen |
collection | DOAJ |
description | Human cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV genes by co-expression with the HLA class II (HLA-II)-inducing transcription coordinator class II transactivator (CIITA). We identified the latency regulator pUS28 as an interaction factor and potent viral antagonist of CIITA-driven expression of CD74, HLA-DR, HLA-DM, HLA-DQ, and HLA-DP. Both wt-pUS28 and a mutant incapable of inducing G protein-coupled signaling (R129A), but not a mutant lacking the C-terminus, drastically reduced the CIITA protein abundance post-transcriptionally. While control CD4 + T cells from HCMV-seropositive individuals vigorously responded to CIITA-expressing cells decorated with HCMV antigens, pUS28 expression was sufficient to inhibit HLA-II induction and immune recognition by HCMV-specific CD4 + T cells. Our data uncover pUS28 to be employed by HCMV to evade HLA-II-mediated recognition by CD4 + T cells. |
format | Article |
id | doaj-art-7d13baad636e4cb4ac2c27cba3bb1f95 |
institution | Matheson Library |
issn | 2050-084X |
language | English |
publishDate | 2025-07-01 |
publisher | eLife Sciences Publications Ltd |
record_format | Article |
series | eLife |
spelling | doaj-art-7d13baad636e4cb4ac2c27cba3bb1f952025-07-03T15:01:46ZengeLife Sciences Publications LtdeLife2050-084X2025-07-011410.7554/eLife.96414The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAFabienne Maassen0https://orcid.org/0009-0004-3535-3727Vu Thuy Khanh Le-Trilling1https://orcid.org/0000-0002-2733-3732Luisa Betke2https://orcid.org/0009-0008-6767-6239Thilo Bracht3Corinna Siegmund4https://orcid.org/0000-0002-1371-0779Malte Bayer5https://orcid.org/0000-0003-1060-8856Benjamin Katschinski6https://orcid.org/0000-0002-1314-2820Antonia Belter7https://orcid.org/0009-0005-4409-1447Tanja Becker8Denise Mennerich9Sebastian Voigt10Lori Frappier11Barbara Sitek12Katharina Fleischhauer13Mirko Trilling14https://orcid.org/0000-0003-3659-3541Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for the Research on HIV and AIDS‐associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Molecular Genetics, University of Toronto, Toronto, CanadaMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Heidelberg, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for the Research on HIV and AIDS‐associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyHuman cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV genes by co-expression with the HLA class II (HLA-II)-inducing transcription coordinator class II transactivator (CIITA). We identified the latency regulator pUS28 as an interaction factor and potent viral antagonist of CIITA-driven expression of CD74, HLA-DR, HLA-DM, HLA-DQ, and HLA-DP. Both wt-pUS28 and a mutant incapable of inducing G protein-coupled signaling (R129A), but not a mutant lacking the C-terminus, drastically reduced the CIITA protein abundance post-transcriptionally. While control CD4 + T cells from HCMV-seropositive individuals vigorously responded to CIITA-expressing cells decorated with HCMV antigens, pUS28 expression was sufficient to inhibit HLA-II induction and immune recognition by HCMV-specific CD4 + T cells. Our data uncover pUS28 to be employed by HCMV to evade HLA-II-mediated recognition by CD4 + T cells.https://elifesciences.org/articles/96414Human cytomegalovirusHCMVhuman herpesvirus 5HHV-5US28HLA class II |
spellingShingle | Fabienne Maassen Vu Thuy Khanh Le-Trilling Luisa Betke Thilo Bracht Corinna Siegmund Malte Bayer Benjamin Katschinski Antonia Belter Tanja Becker Denise Mennerich Sebastian Voigt Lori Frappier Barbara Sitek Katharina Fleischhauer Mirko Trilling The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA eLife Human cytomegalovirus HCMV human herpesvirus 5 HHV-5 US28 HLA class II |
title | The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA |
title_full | The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA |
title_fullStr | The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA |
title_full_unstemmed | The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA |
title_short | The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA |
title_sort | human cytomegalovirus encoded pus28 antagonizes cd4 t cell recognition by targeting ciita |
topic | Human cytomegalovirus HCMV human herpesvirus 5 HHV-5 US28 HLA class II |
url | https://elifesciences.org/articles/96414 |
work_keys_str_mv | AT fabiennemaassen thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT vuthuykhanhletrilling thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT luisabetke thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT thilobracht thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT corinnasiegmund thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT maltebayer thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT benjaminkatschinski thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT antoniabelter thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT tanjabecker thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT denisemennerich thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT sebastianvoigt thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT lorifrappier thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT barbarasitek thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT katharinafleischhauer thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT mirkotrilling thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT fabiennemaassen humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT vuthuykhanhletrilling humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT luisabetke humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT thilobracht humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT corinnasiegmund humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT maltebayer humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT benjaminkatschinski humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT antoniabelter humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT tanjabecker humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT denisemennerich humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT sebastianvoigt humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT lorifrappier humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT barbarasitek humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT katharinafleischhauer humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita AT mirkotrilling humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita |